http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010006425-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c87938e600391373c35c0f44f69fa01f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77241a281eb64addb894b98147b43e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f816c5a80257c6e3c2c0e2a25f0794ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_744bd5fc99d442a62eb65600a2392ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_896beb27aad3647a601b130f2032dddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9c306da13f6794f2cc45af21b2892c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8160849125c1914f02de022edf2f2f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bbcce032ae08eed8d1f80490edb594e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69e2e856c1790cfa1c21ca7081a15d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572a8bb32e83d0f807d4b2af61d256a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556d3ea4bb7c5eaf1f4f0292f0dd4654
publicationDate 2010-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010006425-A
titleOfInvention MODULATORS OF PROTEIN KINASE OF MULTIPLE OBJECTIVES 1,3-CYCLOPENTADIONA-SUBSTITUTED CANCER, ANGIOGENESIS AND THE INFLAMMATORY TRAJECTORIES ASSOCIATED WITH THE SAME.
abstract Compounds and methods for multi-purpose protein kinase modulation for the treatment of angiogenesis, cancer, or the inflammatory trajectories associated with those conditions are described. The compounds and methods described are based on 1,3-cyclopentadione-substituted compounds.
priorityDate 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583699

Total number of triples: 27.